Fesoterodine Fumarate recalls

Fesoterodine Fumarate products have been recalled 2 times, most recently on 14 Jan 2026. The recalling company is usually Alembic Pharmaceuticals. The most common reason is potency & assay.

Total recalls2since 2025

Last 12 months2reported

Class I00% of total

Ongoing2latest 14 Jan 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 1Nov 0 1 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why fesoterodine fumarate is recalled

Potency & Assay2100%

Companies

Alembic Pharmaceuticals2100%

By year

2026150%
2025150%

Ongoing fesoterodine fumarate recalls

2 active

Reported	Class	Recall	Company	Reason	Where
14 Jan 2026Drug	CLASS III	Fesoterodine Fumarate, Extended-release Tablets, 8 mg recalledFesoterodine Fumarate	Alembic Pharmaceuticals	Potency & Assay	Nationwide
26 Nov 2025Drug	CLASS III	Fesoterodine Fumarate, Extended-release Tablets, 4 mg recalledFesoterodine Fumarate	Alembic Pharmaceuticals	Potency & Assay	Nationwide

All fesoterodine fumarate recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
14 Jan 2026Drug	CLASS III	Fesoterodine Fumarate, Extended-release Tablets, 8 mg recalledFesoterodine Fumarate	Alembic Pharmaceuticals	Potency & Assay	Nationwide
26 Nov 2025Drug	CLASS III	Fesoterodine Fumarate, Extended-release Tablets, 4 mg recalledFesoterodine Fumarate	Alembic Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.